EMPIGET-M 12.5/1000 EMPAGLIFLOZIN 12.5MG/METFORMIN 1000MG 28’S

Empiget-M 12.5/1000 is a combination medication containing Empagliflozin 12.5 mg and Metformin 1000 mg. It is primarily used for the management of type 2 diabetes mellitus in adults. Empagliflozin, a sodium-glucose co-transporter 2 (SGLT2) inhibitor, helps lower blood sugar levels by preventing glucose reabsorption in the kidneys, promoting its excretion through urine. Metformin, a biguanide, enhances insulin sensitivity and reduces hepatic glucose production, making it a cornerstone in diabetes management.

This combination not only aids in controlling blood sugar levels but also contributes to weight loss and may reduce the risk of cardiovascular events in diabetic patients. Empiget-M is particularly beneficial for patients who require dual therapy to achieve optimal glycemic control. In Kenya, it is essential for healthcare providers to consider this medication for effective diabetes management, ensuring better health outcomes for patients.